Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patients

BACKGROUND: Circulating tumor DNA (ctDNA) is a non-invasive biomarker for evaluating cancer prognosis. The aim of this study was to analyze the genomic profile of circulating tumor DNA (ctDNA) in breast cancer patients, and evaluate its clinical implications. METHODS: Targeted sequencing of ctDNA wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Hyoeun, Kwon, Min Jeong, Park, In Hae, Kim, Min Kyeong, Cho, Eun-Hae, Lee, Junnam, Lee, Seung-Tae, Sim, Sung Hoon, Lee, Keun Seok, Kim, Yun-Hee, Kim, Seok-Ki, Lee, Eun Sook, Kong, Sun-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848433/
https://www.ncbi.nlm.nih.gov/pubmed/35282050
http://dx.doi.org/10.21037/atm-21-4881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8848433/
https://www.ncbi.nlm.nih.gov/pubmed/35282050
http://dx.doi.org/10.21037/atm-21-4881

Ejemplares similares